文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种基于日本分类法的新病理评分系统,用于预测糖尿病肾病的肾脏预后。

A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

作者信息

Hoshino Junichi, Furuichi Kengo, Yamanouchi Masayuki, Mise Koki, Sekine Akinari, Kawada Masahiro, Sumida Keiichi, Hiramatsu Rikako, Hasegawa Eiko, Hayami Noriko, Suwabe Tatsuya, Sawa Naoki, Hara Shigeko, Fujii Takeshi, Ohashi Kenichi, Kitagawa Kiyoki, Toyama Tadashi, Shimizu Miho, Takaichi Kenmei, Ubara Yoshifumi, Wada Takashi

机构信息

Nephrology Center, Toranomon Hospital, Tokyo, Japan.

Okinaka Memorial Institute for Medical Research, Tokyo, Japan.

出版信息

PLoS One. 2018 Feb 6;13(2):e0190923. doi: 10.1371/journal.pone.0190923. eCollection 2018.


DOI:10.1371/journal.pone.0190923
PMID:29408865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5800536/
Abstract

BACKGROUND AND OBJECTIVES: The impact of the newly proposed pathological classification by the Japan Renal Pathology Society (JRPS) on renal outcome is unclear. So we evaluated that impact and created a new pathological scoring to predict outcome using this classification. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A multicenter cohort of 493 biopsy-proven Japanese patients with diabetic nephropathy (DN) were analyzed. The association between each pathological factor-Tervaert' and JRPS classifications-and renal outcome (dialysis initiation or 50% eGFR decline) was estimated by adjusted Cox regression. The overall pathological risk score (J-score) was calculated, whereupon its predictive ability for 10-year risk of renal outcome was evaluated. RESULTS: The J-scores of diffuse lesion classes 2 or 3, GBM doubling class 3, presence of mesangiolysis, polar vasculosis, and arteriolar hyalinosis were, respectively, 1, 2, 4, 1, and 2. The scores of IFTA classes 1, 2, and 3 were, respectively, 3, 4, and 4, and those of interstitial inflammation classes 1, 2, and 3 were 5, 5, and 4 (J-score range, 0-19). Renal survival curves, when dividing into four J-score grades (0-5, 6-10, 11-15, and 16-19), were significantly different from each other (p<0.01, log-rank test). After adjusting clinical factors, the J-score was a significant predictor of renal outcome. Ability to predict 10-year renal outcome was improved when the J-score was added to the basic model: c-statistics from 0.661 to 0.685; category-free net reclassification improvement, 0.154 (-0.040, 0.349, p = 0.12); and integrated discrimination improvement, 0.015 (0.003, 0.028, p = 0.02). CONCLUSIONS: Mesangiolysis, polar vasculosis, and doubling of GBM-features of the JRPS system-were significantly associated with renal outcome. Prediction of DN patients' renal outcome was better with the J-score than without it.

摘要

背景与目的:日本肾脏病理学会(JRPS)新提出的病理分类对肾脏预后的影响尚不清楚。因此,我们评估了这种影响,并使用该分类创建了一种新的病理评分来预测预后。 设计、设置、参与者与测量:对493例经活检证实的日本糖尿病肾病(DN)患者的多中心队列进行了分析。通过调整后的Cox回归估计每个病理因素(特尔瓦特分类和JRPS分类)与肾脏预后(开始透析或估算肾小球滤过率[eGFR]下降50%)之间的关联。计算总体病理风险评分(J评分),并评估其对10年肾脏预后风险的预测能力。 结果:弥漫性病变2级或3级、肾小球基底膜(GBM)增厚3级、存在系膜溶解、极周血管病变和小动脉玻璃样变的J评分分别为1、2、4、1和2。肾小管间质纤维化(IFTA)1级、2级和3级的评分分别为3、4和4,间质炎症1级、2级和3级的评分分别为5、5和4(J评分范围为0 - 19)。当分为四个J评分等级(0 - 5、6 - 10、11 - 15和16 - 19)时,肾脏生存曲线彼此有显著差异(p<0.01,对数秩检验)。在调整临床因素后,J评分是肾脏预后的显著预测指标。将J评分添加到基本模型中时,预测10年肾脏预后的能力有所提高:c统计量从0.661提高到0.685;无类别净重新分类改善为0.154(-0.040,0.349,p = 0.12);综合判别改善为0.015(0.003,0.028,p = 0.02)。 结论:系膜溶解、极周血管病变和GBM增厚(JRPS系统的特征)与肾脏预后显著相关。使用J评分预测DN患者的肾脏预后比不使用时更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/5800536/ce7005674779/pone.0190923.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/5800536/ff98b5fcab01/pone.0190923.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/5800536/ce7005674779/pone.0190923.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/5800536/ff98b5fcab01/pone.0190923.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/5800536/ce7005674779/pone.0190923.g002.jpg

相似文献

[1]
A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

PLoS One. 2018-2-6

[2]
A pathological scoring system to predict renal outcome in diabetic nephropathy.

Am J Nephrol. 2015

[3]
Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.

PLoS One. 2018-1-16

[4]
Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy.

Kidney Res Clin Pract. 2022-9

[5]
Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Clin Exp Nephrol. 2018-6

[6]
Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.

Clin J Am Soc Nephrol. 2016-4-7

[7]
Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.

Diabetes Metab Res Rev. 2015-9

[8]
Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.

J Diabetes Complications. 2016-4

[9]
Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification.

Medicine (Baltimore). 2019-7

[10]
Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.

Nephrology (Carlton). 2012-1

引用本文的文献

[1]
Machine learning-based prediction of tubulointerstitial lesions in diabetic kidney disease: a multicenter validation study.

Ren Fail. 2025-12

[2]
Investigating the role of gut microbiota in diabetic nephropathy through plasma proteome mediated analysis.

Sci Rep. 2025-2-14

[3]
Association of pulse pressure with incident end-stage kidney disease according to histopathological kidney findings in patients with diabetic nephropathy.

Hypertens Res. 2024-11

[4]
Clinical and histopathological characteristics of primary focal segmental glomerulosclerosis in Turkish adults.

Sci Rep. 2024-3-21

[5]
Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study.

Front Immunol. 2023

[6]
Urinary growth differentiation factor 15 predicts renal function decline in diabetic kidney disease.

Sci Rep. 2023-8-2

[7]
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.

J Diabetes Investig. 2023-11

[8]
Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy.

Kidney Res Clin Pract. 2022-9

[9]
Renal Histologic Findings in Necropsies of Type 2 Diabetes Mellitus Patients.

J Diabetes Res. 2022

[10]
Diosmin mitigates high glucose-induced endoplasmic reticulum stress through PI3K/AKT pathway in HK-2 cells.

BMC Complement Med Ther. 2022-4-27

本文引用的文献

[1]
Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes.

Nephrol Dial Transplant. 2018-1-1

[2]
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Lancet. 2016-4-9

[3]
Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.

Clin J Am Soc Nephrol. 2016-4-7

[4]
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

JAMA. 2016-1-12

[5]
A pathological scoring system to predict renal outcome in diabetic nephropathy.

Am J Nephrol. 2015

[6]
Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy.

Diabet Med. 2015-4

[7]
Renal histologic changes and the outcome in patients with diabetic nephropathy.

Nephrol Dial Transplant. 2015-2

[8]
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values.

J Diabetes Investig. 2012-2-20

[9]
Is diabetic nephropathy reversible?

Diabetes Res Clin Pract. 2014-6

[10]
Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.

Nephrol Dial Transplant. 2013-10-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索